Abstracts Published

  1. Singh S, Samantaray JC, Kumar R. Intestinal parasitosis in and around Delhi. XXXINational Conference of ISG at Jaipur on November, 25-29, 1990.
  2. Singh S, Irshad M, Shrivastava AK Rattan A. Blood contamination of laboratory slips and blood sample containers: a risk of laboratory acquired infections. Proceeding of VII International Conference on AIDS, Florence, Italy, 1991. vol 7; 434.
  3. Singh S, Sharma MP. Strongyloidiasis in Northern India. 32nd National Conference of ISG at Triv andrum on October, 6-9, 1991.
  4. Wali JP, Aggarwal P, Gupta U, Singh S. Ketoconazole in the treatment of drug resistant Kala-azar. J Assoc. Phys Indian 1991; 39: 867-8.
  5. Singh S, Seth P. Toxoplasmosis in AIDS patients in India. Proceeding of second International Conference on AIDS in Asia and the Pacific, New Delhi, 1992.
  6. Singh S, Seth P, Dubey JP. Toxoplasmosis in Indian AIDS patients. Proceeding of VIII International Conference on AIDS, Amsterdam, The Netherl ands, 1992.
  7. Singh S, Singh N. Toxoplasmosis is sexually transmitted. Proceeding of IX International Conference on AIDS, Berlin, Germany, 1993.
  8. Singh S, Singh N, Karmarkar MG. Evaluation of Direct agglutination test and ELISA for the diagnosis of toxoplasmosis. XIX National Conference of Indian Immunology Society, Bangalore, January 8-11, 1993.
  9. Singh S, Singh N, Lakra MS. Blastocystis hominis in patients with gastrointestinal symptoms. 34th National congress of ISG, Panji (Goa), October 13-17, 1993.
  10. Handa R, Singh S, Singh N, Wali JP. Brucellosis in India. Proceeding of the 6th International Congress for Infectious Diseases, Prague, Czechoslovakia, 1994.
  11. Singh S, Singh N, ManiarJK, Saple DG, Seth T. Human Tumour necrosis factor- in AIDS associated Toxoplasmosis. Proceeding of X International Conference on AIDS, Yokohama, Japan, 1994.
  12. Singh N, Singh S. Vaginal fluid collected with OMNI-SAL collection device as an alternative to serum for immunodiagnosis. Proceeding of X International Conference on AIDS, Yokohama, Japan, 1994.
  13. Singh S, Ahlawat S, Singh N, Chaudhary VP. TORCH Infections in multiply transfused Thalassemic Indian Children. 3rd International Conference of the Hospital Infection Society, London, 1994.
  14. Singh S, Chang KP. Genetic heterogeneity among Indian Leishmania donovani isolates. Proceeding of VIII International Congress of Parasitology, Izmir, Turkey, 1994.
  15. Singh S, Chang KP. Diagnostic & Prognostic evaluation of rK39 antigen in Indian Leishmaniasis. Proceedings of the 43rd Congress of American Society of Tropical Medicine & Hygiene, Cincinnati, USA, 1994.
  16. Singh S, Singh N, Raju GV. Knowledge, attitude & beliefs about AIDS & sexuality in Medical and Paramedical staff of a teaching hospital. Proceeding of the III International Conference on AIDS in Asia and the Pacific, Chiang-Mai, Thail and, 1995.
  17. Singh S. Molecular tools for the diagnosis of Toxoplasmosis. National Symposium on Toxoplasmosis in India. New Delhi, September 27-28, 1995.
  18. Singh S. Cytokines in toxoplasmosis. National Symposium on Toxoplasmosis in India. New Delhi, September 27-28, 1995.
  19. Singh S, Singh N, Rattan A. TORCH Infections. International CME on Laboratory Approach to Paediatric Problems. New Delhi, 1995.
  20. Singh S. Immunodiagnosis of Indian Leishmaniasis. Global Meet on Parasitic Diseases, New Delhi, 1996.
  21. Singh S, Singh N, ManiarJK. TNF- in AIDS Associated Toxoplasmosis. Global Meet on Parasitic Diseases, New Delhi, 1996.
  22. Singh S*. AIDS Associated Toxoplasmosis: An Indian Scene (Awarded Paper). Proceedings of 9th International Symposium on Infections in the Immuno-compromised Host. Assisi, Italy, 1996.
  23. Singh S, Singh N, Handa R. Serum concentrations of Tumour necrosis factor- in Indian patients with Malaria and Kala-azar: its correlation with disease prognosis. 7th International Congress for the Infectious Diseases, Hong-Kong, June 10-13, 1996 [Abs: 10146].
  24. Singh S, Singh N. Human Immunodeficiency virus reaches small villages in rural India. Proceedings of the XI International Conference on AIDS. Vancouver, Canada, July 6-11, 1996.
  25. Chang KP, Chai JJ, Zho XP, Qu JQ, Sundar S, Singh S, Reed SG. RK39 Dipstick vs. conventional procedures for diagnosis of Chinese and Indian visceral Leishmaniasis. XIV International Congress for Tropical Medicine & Malaria. Nagasaki, Japan, Nov. 17-22, 1996.
  26. Wali JP & Singh S. Tuberculosis as occupational Hazard in Health Care workers. International Conference on Communicable Diseases as Occupational Hazard. Tel-Aviv, February 18-21, 1996.
  27. Singh S, Chang KP and Reed SG. Anti-Leishmanial antibodies in asymptomatic family members of Kala-azar patients of Bihar. Second Global Meet on Parasitic Diseases, Hyderabad, India, August 18-22, 1997.
  28. Singh S, Lakra MS. Giardia lamblia in school children, Annual Conference of ISG, Chandigarh, October 1997.
  29. Singh S, Shalini, Modi G. Misdiagnosed case of Listeria monocytogenes infection in renal transplant patient. 35th National Conference of IAMM, Manipal, Nov. 6-9, 1998.
  30. Singh S, Mohapatra DP, Shivakumar R, Kumar J. Urine as growth supplement for Leishmania donovani. 13th National Conference of Parasitology, Bangalore, February 24-26, 1999.
  31. Mohapatra DP, Singh S. 13th National Conference of Parasitology, Bangalore, February 24-26, 1999.
  32. Sivakumar R, Singh S, Mohapatra DP, Saba Shahdad, Kumar J. 13th National Conference of Parasitology, Bangalore, February 24-26, 1999.
  33. Singh S. Free living amoebas in intermittently chlorinated drinking water of Delhi- India. ISID Congress, Boston, USA, 1998.
  34. Singh S, Kumar J, Singh R. Spread of HIV and hepatitis viruses through the use of injection needles for Kala-azar therapy, in India. XII International AIDS Conference, Geneva, Switzerland, June-July 1998.
  35. Singh S, Prasad R, Mohanty A. HIV and Hepatitis -B viral infections in Jailmates of Ghaziabad, North India. XII International AIDS Conference, Geneva, Switzerland, June-July 1998.
  36. Singh S, Kumari V, Kumar J, Singh N, Kumar L. Cytomegalovirus reactivation in bone marrow transplant recipients: Indian experience. 10th International Symposium of International Immunocompromised Host Society, Davos, Switzerland, June 1998.
  37. Singh S, Singh N, Kumar J. Th1 and Th2 type responses in Kala-azar patients. 10th International Conference of Immunology, New Delhi, November 1-6, 1998.
  38. Singh S. Death due to Malaria: its forensic aspects. International Conference and Workshop on recent advances in medical Toxicology and Legal Medicine. New Delhi, November 2-7, 1998.
  39. Singh S. Epidemiology and economic issues of HIV in the Third world. International CME of American College of Physicians and American Association of Physicians from India, Hyderabad August 12-14, 1999.
  40. Singh S. ICMR-WHO symposium on Kala-azar. Gave a talk on “problems associated with repeated injection treatment in kala-azar patients”. The symposium was held on December 18-19, 2000, at Hotel Imperial, New Delhi.
  41. Singh S, Kumari Veena. HIV transmission kinetics in discordant Indian couples. Proceedings of the XIII International Congress of AIDS. Durban, July, 2000 vol. 13, [MoPeB2165].
  42. Singh S. Hospital Infection Control: Practices and Guidelines. Proceedings of First National Conference of Laboratory Medicine January 27-29, 2000 (Pl-3).
  43. Shahdad S, Rattan A, Singh S Species determination of Mycobacteria isolated from AIDS patients in India by 16s rRNA sequencing. Proceedings of National Conference of Laboratory Medicine January 27-29, 2000 (O-12).
  44. Astha, Kumari Veena, Singh N, Sivakumar R, Garg S, Kumar N, Singh S Congenital CMV infection: Indian Scenario. Proceedings of First National Conference of Laboratory Medicine, January 27-29, 2000 (O-19).
  45. Shahdad S, Rattan A, Singh S Molecular analysis of is oniazid resistant clinical isolates of M. tuberculosis in India. Proceedings of First National Conference of Laboratory Medicine January 27-29, 2000 (PP-12).
  46. Kumari Veena, Kumar B, Mohapatra DP, Singh S Easy and cost effective diagnosis of Toxoplasmosis on Human serum samples using a modified direct agglutination test (DAT) and its comparison with ELISA. Proceedings of First National Conference of Laboratory Medicine, January 27-29, 2000 (PP-13).
  47. Kidwai MK, Kumar B, Kumar R, Lakra MS, Sood S, Singh S Spectrum of Intestinal Parasitic infections in HIV positive patients presenting at AIIMS. Proceedings of First National Conference of Laboratory Medicine January 27-29, 2000 (PP-14).
  48. Singh S,Agarwal S, Kumari V, Kumar R, Astha, Kidwai MK, Sood S. Automation in Microbiology at AIIMs, New Delhi. Proceedings of First National Conference of Laboratory Medicine January 27-29, 2000 (PP-15).
  49. Kumar B, Agarwal S, Astha, Sharma Omvati, Singh S. Laboratory Diagnosis of extrapulmonary tuberculosis. Proceedings of First National Conference of Laboratory Medicine January 27-29, 2000 (PP-16).
  50. Singh S. Shalini Singhal, Niladri Mal, MS Lakra. Identification of conventional and opportunistic intestinal parasites in HIV infected patients in a city based north Indian referral hospital. Proceedings of ASCODD. New Delhi, October, 2001.
  51. Singh S, Kumari Veena, Shalini Singhal, Niti Singh. An Indian herbal immunomodulator: Highly effective in the treatment of HIV/AIDS. Proceedings of 6th International Conference on AIDS in Asia Pacific, Melbourne, Australia. October, 2001. [WePo 1254].
  52. Singh S. Prevention of spread of HIV and hepatitis viruses. Proceedings of 3rd International Conference of AIDS India 2000, Chennai, December, 2001.
  53. Singh S. Recent advances in the Laboratory Diagnosis of Leishmaniasis. International Symposium on Leishmaniasis. New Delhi. February 23-24, 2002.
  54. Singh S, S. Shahdad. High Rate of Drug Resistance in the Isolates of Mycobacterium Tuberculosis from India: Determined by PCR-RFLP of Kat-G Gene. Abstract: 40.009. Abstract Book of the 10th International Congress on Infectious Diseases, Singapore, March 7-11, 2002, page 101.
  55. Shahdad S, Singh S. Species Determination of Mycobacteria Isolated from AIDS Patients in India by 16s rRNA Sequencing. Abstract: 40.019. Abstract Book of the 10th International Congress on Infectious Diseases, Singapore, March 5-11, 2002, page 103.
  56. Singh N, Singh S, Chanaveerappa B, Wali JP. Active Cytomegalovirus Infection in Indian AIDS Patients Detected by Nested Polymerase Chain Reaction. Abstract: 75.105. Abstract Book of the 10th International Congress on Infectious Diseases, Singapore, March 2002, page 210.
  57. Singh S, Niti Singh, R. Sivakumar. Diagnostic and prognostic value of Nested Polymerase Chain Reaction in the post-transplant reactivation of CMV infection. XII International Symposium of Immunocompromised Host Society (ICHS) at Bergen (Norway). June 22-27, 2002.
  58. Singh S, Kumari Veena, Shalini Singhal, Niti Singh.Prevalence of HIV infection in Tuberculosis patients of Northern India. XIV World AIDS Conference, Barcelona (Spain) July 7-12, 2002. Abstract #ThPeB7274.
  59. Singh S, Singh N, Balooni Veena, Shalini Singhal. Psycho-social aspects of AIDS Epidemic in India XIV World AIDS Conference, Barcelona (Spain) July 7-12, 2002. Abstract # WePeC6242.
  60. Tripathi BM, Singh S, Pal H. HCV and HIV infection among intravenous drug users attending a Drug Dependence Treatment Centre in India. Int Conf AIDS 2002 Jul 7-12; 14: (abstract no. C10974).
  61. Shahdad S, Katoch VM, Hasnain SE, Rattan A, Singh S. Species determination of mycobacteria isolated from environmental samples in India by 16 S rRNA sequence. LABCON-2, New Delhi. February 21-22, 2002.
  62. Sivakumar R, Singh S. Cloning of kinesin gene related antigen gene from an Indian isolate of Leishmania donovani. LABCON-2, New Delhi. February 21-22, 2002.
  63. Kaur M, Kumar B, Kishore N, Sivakumar R, Singh S. Utility of automated mycobacterial culture system (BACTEC-960) and PCR technique for mycobacterial disease diagnosis- a preliminary study. LABCON-2, New Delhi. February 21-22, 2002.
  64. Singh N, Singh S, Sivakumar R, Agarwal SK, Kumar Lalit, Tiwari SC, Dash SC. Diagnostic and prognostic value of nested PCR in the reactivation of CMV infection in the post organ transplant cases. LABCON-2, New Delhi. February 21-22, 2002.
  65. Singh S, Sivakumar R, Kaur M , Singh B, Sharma P. Screening for SNPs (Single nucleotide polymorphism in the tumour necrosis factor alpha promotor region. LABCON-2, New Delhi. February 21-22, 2002.
  66. Singh S, Kumari Veena, Agarwal S, Singh N. Efficacy of an Indian herbal immunomodulator in the treatment of HIV/AIDS. LABCON-2, New Delhi. February 21-22, 2002.
  67. Singh S. Sir Dorabji Tata memorial Symposium on Diarrhoeal diseases. Bangalore, March 22-23, 2002.
  68. Singh S, Kumar B, Kumar J, Astha, Singhal S. Biological Contamination of Delhi drinking water. LABCON-2, New Delhi. February 21-22, 2002.
  1. Singhal S, Kumar B, Lakra MS, Singh S. Prevalence of intestinal parasites in HIV-infected patients seen at a tertiary care North Indian Hospital. LABCON-2, New Delhi. February 21-22, 2002.
  2. Singh S, Balooni Veena, Singh Niti, Sivakumar Ramu. Predicting kala-azar in Leishmania donovani infected asymptomatic patients. XXVI Annual Conference of IAMM. Bangalore. November 21-24, 2002.
  3. Singh S. Recent advances in diagnosing Toxoplasmosis in immunocompetant and immunocompromised patients. 27th National Conference of IAMM, Mumbai, November 5- 9, 2003.
  4. Kaur M, Saluja TP, Singh B, Sharma P, Singh S. Comparative evaluation of Mycobacteriophage assay and automated MGIT-960 culture method with PCR using a novel set of primers for diagnosing tuberculosis. 27th National Conference of IAMM,Mumbai, November 5- 9, 2003.
  5. Singh S. Virology of HIV. 3rd International Conference on Integrated Medicine, organised by Mediciti, Hyderabad and Indian Association of Physicians of America. January 4-5, 2003.
  6. Singh S. Post-exposure prophylaxis in HIV/AIDS prevention. 4th International Conference on AIDS India Chennai, November 9-12, 2003.
  7. Singh S. High rate of Multi-drug resistant tuberculosis in India: amajor challenge for AIDS prevention measures. 8th International Conference on Emerging Infectious Diseases in Pacific Rim”, Dhaka, December 11-12, 2003.
  8. Singh S. Shahdad S, Rattan A, Katoch VM, Hasnain SE. Predominance of non-tubercular Mycobacteria in Indian AIDS patients as speciated by molecular methods. ICMR-INSERM workshop on Tuberculosis. Agra, December 12-14, 2003.
  9. ManjotKaur, Singh S. Detection and Identification of Mycobacteria by PCR Amplification of 16-23S internal Transcribed Spacer Regions directly from clinical samples. International Conference on Recent Advances in Biomedical and Therapeutic Sciences. Bundelkh and University, Jhansi, India, January 13-15, 2004.
  10. Sivalumar R, Singh S. Development of Recombinant antigen for the diagnosis of Kala-Azar in India. International Conference on Recent Advances in Biomedical and Therapeutic Sciences. Bundelkh and University, Jhansi, India, January 13-15, 2004.
  11. Singh N, Singh S, Bisen PS, Chandra R. Evaluation of diagnostic and prognostic value of nested-Polymerase Chain Reaction in the reactivation of Cytomegalovirus infection in Renal Transplant Recipients . International Conference on Recent Advances in Biomedical and Therapeutic Sciences. Bundelkh and University, Jhansi, India, January 13-15, 2004.
  12. Kothari S, Sivakumar R, Singh N, Singh S. Genotype & Allele Frequency of a 32-Base pair deletion mutation in the CCR5 gene among Indian Population. International Conference on Recent Advances in Biomedical and Therapeutic Sciences. Bundelkh and University, Jhansi, India, January 13-15, 2004.
  13. Singh S. Kaur M. Emergence of multi-drug resistant Mycobacterium tuberculosis in India. 11th International Conference on Infectious Disease, Cancun, Mexico, March 4-8, 2004.
  14. Shahdad S, KatochVM, Hasnain SE, Rattan A, Singh S. Genomes 2004. The Institute of Genome Research/ Welcome Trust Conference, Hinxton, Cambridge. 14 -17 April. 2004.
  15. Singh S. Non-Tubercular Mycobacteria in Indian AIDS patients. Biomeriux Science Foundation International Conference on Tuberculosis. Annecy, France. July 1-4, 2004.
  16. Singh S. Update on HIV in India.. 10th Annual International Continuing Medical Education Program HIV Update at MediCiti Hyderabad, India. August 7-8, 2004.
  17. Singh S, Balooni V, Singhal S, Singh N. Socio-behavioral aspects o AIDS care in India. The XV International AIDS Conference, Bangkok, Thailand, 2004. Abstract #. MoPeD3736.
  18. Singh S.Non-tubercular Mycobacteria in Indian AIDS patients. International Symposium on Emerging Trends in Tuberculosis. ICGEB, New Delhi, November 15-17, 2004.
  19. Singh S. Social and behavioural aspects of HIV/ AIDS care in India. First Asia /Pacific Conference on Women, Girls & HIV /AIDS Best Practices, Islamabad, Pakistan. November 31-December 1, 2004.
  20. Singh S, &ManjotKaur. High rate of Multidrug Resistant M. tuberculosis in India. 9th International Conference on Emerging Infectious Diseases, Kyoto, Japan, December 7-10, 2004.
  21. Mittal CM, Wig N, Anupama P, Mishra S, Singh S. Tumour necrosis factor-alpha and cardiac function in HIV patients. IntConf AIDS 2004, Bangkok, Thailand, Jul 11-16; 15 :(abstract no. A10315).
  22. Singh S. Non-tubercular Mycobacteria in AIDS: Mid-term national update on Infectious diseases and clinical Microbiology at Sri Nagar; October 1-3, 2004.
  23. Singh S. Recent Advances in the Diagnosis of Leishmaniasis. 28th National Conference of IAMM, Lucknow, November 25- 28, 2004.
  24. Singh S. Diagnosis of acute Toxoplasmosis by avidity test. 29th National Conference of Indian Association of Medical Microbiologists, Chennai, October 21- 23, 2005.
  25. Singh S. Food Borne Toxoplasmosis. 17th National Congress of Parasitology. Held at Dibrugarh, Assam, October 24-26, 2005.
  26. Kaur M, Singh S. Rapid Diagnosis of pulmonary and extra-pulmonary tuberculosis by PCR Amplification of 16-23S ITS Regions directly from clinical samples. International Conference on Functional Genomics for Vaccine & Novel Drug Design against Mycobacteria, IITKharagpur (WB) February 10-14, 2005.
  27. Singh S. Molecular Epidemiology of Non-Tubercular Mycobacterial in Indian AIDS patients. International Conference on Functional Genomics for Vaccine & Novel Drug Design against Mycobacteria. IITKharagpur (WB), February 10-14, 2005.
  28. Sivakumar R, Balooni V, Sharma P, Chang KP,Singh S. Diagnosis of visceral and post-kala-azar dermal leishmaniasis using a novel recombinant antigen prepared from an Indian isolate of Leishmania donovani. Intracellular Pathogens, During the Asian Regional Workshop on Emerging Infectious Diseases, Seattle Biomedical Research centre, USA and JNU, India, New Delhi, March 8-10, 2005.
  29. Sivakumar R, Balooni B, Sharma P, Chang KP, Singh S. Serodiagnosis of VL And PKDL Using A Novel Recombinant Antigen From A Recent Indian Isolate Of Leishmania Donovani. Third World Congress on Leishmaniasis-WorldLeish3. Sicily, Italy, April 10-15, 2005.
  30. Kaur M, Shahdad S, Sharma P, Singh S. Molecular Epidemiology of Non-Tubercular Mycobacterial in Indian AIDS patients. 3rd International AIDS Society Conference on HIV pathogenesis and treatment. Abstract # TuPe7.2C01. Rio-de-Janeiro, Brazil. July 24-27, 2005.
  31. Singh S. Intestinal Opportunistic Pathogens in Indian AIDS patients seen at a tertiary medical institute in North India. Indo-US workshop on Diarrhoeal diseases held at NICED, Kolkata from October 3-5,
  32. Singh S. Epidemiology of Non-Tubercular Mycobacterial infections in AIDS patients. Fifth International Conference on AIDS in India. Chennai. October 21-24, 2005.
  33. Sharma U,Dey A, Singh S. “First case report of indigenous visceral leishmaniasis from Central India” in International conference on opportunistic pathogens in AIDS held at All India Institute of Medical Sciences, New Delhi, India from 27th-29th March 2006.
  34. Sharma U,Dey A, Singh S. “Leishmania-HIV co-infection: An emerging problem in India” National Conference on Immunology in health and disease 2006 held at ChhatrapatiShahuJiMaharaj University, Kanpur, India from 11th -12th January 2006.
  35. Kumar Sandeep, Singh Niti, Katharya, Dhankhar Pawan, Singh Sarman. “A preliminary Report of Household Contact Investigation for Tuberculosis.”International Symposium on New Frontiers in Tuberculosis Research, Dec 2006, ICGEB, New Delhi.
  36. Singh S. AIDS associated toxoplasmosis. International Conference on Opportunistic Pathogens in AIDS, March 27-29, 2006. New Delhi.
  37. Redhu NS., Dey A, Balooni V and Singh S. HIV-Leishmania Co-infection: A Retrospective Study from India. International Conference on Opportunistic Pathogens in AIDS, March 27-29, 2006., New Delhi.
  38. Gupta S, and HIV Infections. Among Pregnant Women Attending Antenatal Clinics at a Tertiary Care Hospital in India. International Conference on Opportunistic Pathogens in AIDS, March 27-29, 2006., New Delhi.
  39. Gupta R, Gupta S, Mathur P, Aggarwal S, Singh S. Seroprevalence Of Toxoplasma In HIV Positive Vs. HIV Negative Patients In North India. International Conference on Opportunistic Pathogens in AIDS, March 27-29, 2006., New Delhi.
  40. Narang S, Mathur P, Singh S. Intestinal parasite Profile in the Stool sample of HIV Positive patients. International Conference on Opportunistic Pathogens in AIDS, March 27-29, 2006., New Delhi.
  41. Aruna, Matthew J Magee, Singh S. Drug resistant Tuberculosis in Delhi: A prevalence. International Conference on Opportunistic Pathogens in AIDS, March 27-29, 2006., New Delhi.
  42. Gupta S, Mathur P, Gupta R, Balooni V, Singh S. Hepatitis B Virus and Hepatitis C Virus Co-infections in Hiv Positive Patients in India. International Conference on Opportunistic Pathogens in AIDS, March 27-29, 2006, New Delhi.
  43. Mishra J and Singh S. Prevalence of Herpes simplex IgG (1 & 2) and IgM antibodies among women of reproductive age group at a Tertiary Care Hospital of Northern India. International Conference on Opportunistic Pathogens in AIDS, March 27-29, 2006., New Delhi.
  44. Kumar S, Shankar M, Singh S. Tetrazolium Micro plate Assay as a Rapid and Inexpensive Colorimetric Method for Anti-tubercular Drug Susceptibility testing.International Conference on Opportunistic Pathogens in AIDS, March 27-29, 2006., New Delhi.
  45. Singh S, Shahdad S, Sharma P. Non-Tubercular Mycobacterial infections in Indian AIDS patients diagnosed by genus and species specific 16SrRNA and Novel ESAT-6 Polymerase Chain Reaction primers. XVI International AIDS Conference held at Toronto, Canada, August 13-18, 2006.
  46. Singh S. Singh N. Serum cholesterol levels as surrogate marker for HIV diseases progression: May replace repeated CD4+ cell counts in resource limited countries. XVI International AIDS Conference held at Toronto, Canada, August 13-18, 2006
  47. Singh S. Recent advances in the diagnosis of Leishmaniasis. National Conference on “Immunology in Health & Diseases” Institute of Life Sciences, ChhatrapatiShahujiMahraj University, Kanpur, January 11-12, 2006,
  48. Singh S. TORCH investigations and their interpretation. National conference of ISPAT. February 18, 2006, New Delhi.
  49. Singh S. Microarrays in the diagnosis of Parasitic Diseases. Pre-conference CME. XXX National Conference of Medical Microbiologists” at Nagpur, October 26- 27, 2006.
  50. Singh S. Recent advances in the Diagnosis of Leishmaniasis. 18th National Congress of Parasitology” at Kolkata, November 22-24, 2006.
  51. Singh S. Delivered a lecture on “Methods HIV Testing” during the First Hands-on Workshop on Training course on HIV/AIDS for Medical Officers and Laboratory technicians, National Institute of Biologicals, NOIDA, January 16, 2007.
  52. Singh S. Delivered a lecture on “Methods HIV Testing” during the Second Hands-on Workshop on Training course on HIV/AIDS for Medical Officers and Laboratory technicians, National Institute of Biologicals, NOIDA, February 12, 2007.
  53. Singh S. Delivered a lecture on “Methods HIV Testing” during the Third Hands-on Workshop on Training course on HIV/AIDS for Medical Officers and Laboratory technicians, National Institute of Biologicals, NOIDA, February 19, 2007.
  54. Singh S. Provided hands on-training and Delivered a lecture on Recent Advances in the Diagnosis of Leishmaniasis during the Andhra Pradesh Chapter of IAMM, Hyderabad, February 9, 2007.
  55. Singh S. Delivered a lecture on Quality Assurance in Molecular Diagnostics. Microbiology Update. Maulana Azad Medical College, Delhi. March 9, 2007.
  56. Singh S. Lecture on Molecular Epidemiology of Mycobacterium Paratuberculosis. National Seminar & Workshop on Johne’sDisease. Indian Veterinary Research Institute, Izatnagar. August 8, 2007.
  57. Singh S. Delivered guest lecture on indigenous developments in the Leishmania diagnostics. National Conference of Indian Academy of Tropical Parasitology (Tropacon), Chennai, October 6-7, 2007.
  58. Gupta S., Singh S. Horizontal spread of HBV among contacts of HBV-CLD patients. Indian Journal of Gastroenterology March, 2008 vol 27 (supplement 1) S17.
  59. Magee M, Manning G, Gopinath K, Singh S. MDR- tuberculosis in High-Risk Groups of Delhi: Preliminary Results from an On-going Cross-Sectional Study. PS-61292-02. 37th Union World Conference on Lung Health, Paris – France, 31 October – 4 November 2006.
  60. Singh S, Gopinath K, Mani Sankar M, Kumar S. Emergence of XDR-tuberculosis in India. International Conference of Infectious Diseases, Vienna, Austria. February 22-25, 2007: abstract No. 13.029.
  61. Mishra J, Carpenter S, Singh S. Low serum zinc levels in Bihar: Associated with kala-azar endemicity. 34th Indian Immunology Society conference, Pune from 16th -18th December, 2007
  62. Dey A, Redhu NS, Singh S. Kinesin Motor Domain of Leishmania Donovani as future vaccine candidate. Vaccine Conference, Amsterdam, December 13-15, 2007.
  63. Sharma U, Singh S. Leishmanicidal activity and therapeutic potential of some medicinal plants. IX International Symposium on Vectors and Vector Borne Diseases Puri, Orissa (India), 15-17 February 2008.
  64. Singh A, Gopinath K., Sharma P., Singh N., Bisht D., Katoch V.M., Singh S. Proteomic analysis of M. tuberculosis strains sequentially acquired resistance to Isoniazid and Rifampicin. Ninth Dorabji Tata Symposium on Antimicrobial resistance, Indian Institute of Science Campus, Bangalore on 10-11th March, 2008
  65. Gopinath K., Kumar S., Singh S. Prevalence of Mycobacteremia in Indian HIV infected patients detected by MB/BacT automated culture system. International conference on Opportunistic Pathogens in AIDS 2008 (ICOPA-INDIA 2008), New Delhi, January 27-29, 2008.
  66. Gupta S., Balooni V., Singh S. Occult HBV infection in HIV patients: a preliminary study at a tertiary care hospital. International conference on Opportunistic Pathogens in AIDS 2008 (ICOPA-INDIA 2008), New Delhi, January 27-29, 2008.
  67. Sankar M., Gopinath K., Singh S., Evaluating tetrazoliumMicroplate Assay for drug susceptibility testing in Non-tuberculous mycobacterial isolates. International conference on Opportunistic Pathogens in AIDS 2008 (ICOPA-INDIA 2008), New Delhi, January 27-29, 2008.
  68. Kumar M., Sankar M., Malik A, Singh S., Conventional and molecular techniques in detection of Mycobacterium tuberculosis Complex in Human Immunodeficiency Virus Infected Patients. International conference on Opportunistic Pathogens in AIDS 2008 (ICOPA-INDIA 2008), New Delhi, January 27-29, 2008.
  69. Gupta S., Mathur P., Maskey D., Wig N., Singh S. Immune Restoration Syndrome with disseminated penicilliummarneffei and CMV: 1st report from a non-endemic area. International conference on Opportunistic Pathogens in AIDS 2008 (ICOPA-INDIA 2008), New Delhi, January 27-29, 2008.
  70. Gopinath K., Singh A., Singh S. Comparative genomic analysis of ATP Binding Cassettes transporters of M. tuberculosis and avium paratuberculosis. International Conference on Opportunistic Pathogens in AIDS 2008 (ICOPA-INDIA 2008), New Delhi, January 27-29, 2008.
  71. Sharma U, Velpandian T, Sharma P, Singh S. “Development of novel anti-leishmanial herbal compounds and their molecular mechanism of action against Leishmania donovani” in Theoretical and practical course ‘Molecular biology of Leishmania’ held at International Center for Genetic Engineering and Biotechnology, Trieste, Italy from 23th -25th October 2008.
  72. Sharma U, Singh S. “Leishmanicidal activity and Vector Borne Diseases held at Puri, India from 15th -17th February 2008.
  73. Carmen C, Flores M, Pradas MA, Gonzalez R, Neito J, Singh S. Use of Signal –KA kit for the Diagnosis of Visceral Leishmaniasis. Abstract No. 565. 4th World Congress on Leishmaniasis (Worlleish 4), Lucknow, February 3-7, 2009.
  74. Arshi Munawwar, Swati Gupta, VeenaBallooni, Singh S. :Incidence And Prevalence Of Human Herpes Viruses In HIV Positive Patients In India. ASICON-2009. Jaipur (India)
  75. Sharma U, Velpandian T, Sharma P, Singh S. “Demonstration of In vitroantileishmanial activity of active extracts from Indian plants” in WorldLeish 4 held at Central Drug Research Institute, Lucknow, India from 3rd -7th February 2009.
  76. Sharma U, Dharmendra Singh, M. P. Dobhal,Singh S.In vitro anti-leishmanial activity of plumericin, Isolated from Plumeriabicolor” in X International Symposium on Vectors and Vector Borne Diseases held at Goa, India from 4th -6th November 2010.
  77. Singh S. Invited Lecture as visiting Professor: Opportunistic Infections in AIDS Patients: Indian Scenario. NIH, Bethesda, USA, March 5, 2010.
  78. Singh S. Occult hepatitis B virus infection in ART-naive HIV-infected Indian patients. Abstract # 53.0065, 14th International Conference of Infectious Diseases, Miami, Florida, USA, March 8-12, 2010
  79. Lisco A, Munawwar A, Saba E, Grivel J C, Vanpouille C, Singh S, Margolis L.. HIV-1 viral shedding in semen and early events of HIV-1 infection of human cervico-vaginal tissue in an optimized ex vivo World AIDS Conference, Vienna, July 18-23, 2010.
  80. Kumar M, Oliver B, Kumar A, AgarwalU, Price P,Singh S. Levels of IL-18, sCD14&CCL2, CXCL8 and CXCL10 in tubercular Immune Restoration Disease in a North India Population. World AIDS Conference, Vienna, July 18-23, 2010.
  81. Munawwar A, Lisco A, Sharma SK, Gupta S, Vanpouille C, Parashar D, Vats O, GrivelJC, Margolis L, Singh S. CMV Shedding is significantly higher in semen than blood plasma in Indian HIV infected population. Australasian HIV/AIDS Conference (ASHM) 2010, Sydney, October 20-22, 2010.
  82. Kumar M, Oliver B, AgarwalU, Kumar A, Singh S, Price P.Plasma Levels of IL-18, sCD14&CCL2, CXCL8 and CXCL10 in tubercular Immune Restoration Disease in a North India Population. Australasian HIV/AIDS Conference (ASHM) 2010, Sydney, October 20-22, 2010.
  83. Munawwar Arshi, Gupta S, Lisco A, Vanpouille C, Sharma SK, GrivelJC, Margolis L, Singh S.Epstein Barr Virus” A Yet To Be Recognised Virus For Its Role In AIDS : Indian Scenario.ICOPA-2010, New Delhi: September 28-30, 2010.
  84. Munawwar Arshi, Andrea Introini, Christophe Vanpouille, Jean-Charles Grivel, SinghS and Leonid Margolis: The Complex Interplay Of Cytokines/Chemokines And Reactivated Herpesviruses In Semen of HIV-1-Infected Individuals. CROI-2011, Boston (USA). Feb 27-March 2, 2011
  85. Introini A, Lisco A, Munawwar A., Vanpouille C., Grivel J.-C., Singh S, Margolis L.. HIV-1 and reactivated coinfectingherpesviruses rearrange the cytokine network in semen of infected individuals. 6thIAS Conference on HIV Pathogenesis, Treatment and Prevention. Rome, Italy 17-20 July, 2011
  86. Munawwar A, A Lisco, VanpouilleC ,Grivel J C , Sharma S K , Margolis L , Singh S. Mycobacterium Tuberculosis Shedding in Semen increases heterosexual transmission rate of HIV-AIDS impact, 10th International Conference, 12-15.9. 2011 Santa Fe, New Mexico USA.
  87. Tomar AK, Saraswat M, Sooch BS, Singh S, Singh TP, Yadav S. A New Sequence of positively charged Residues BXXXB Can also Characterize Heparin Binding Site 91. International Conference on Frontiers in Reproductive Biotechnology & 21st Annual Meeting of ISSRF, NDRI, Karnal, India, February 9-11, 2011.
  88. Singh S. Host and Parasite factors leading to Drug resistance in Leishmaniasis. Anti-parasitic and anti-cancer drugs. Porto, Portugal, 6-14 September 2011.
  89. Singh S, Mishra J. Mechanisms of Miltefosine resistance in Leishmania donovani. Anti-parasitic and anti-cancer drugs. Porto, Portugal, 6-14 September 2011.
  90. Singh S, et al. Paper presented on Mycobacterial culture yields from gastric aspirates collected with and without sodium bi- carbonate during the 42nd Union World Conference on Lung Health, Lille, France, 26-30 October 2011.
  91. Singh S. Guest Lecture on “Quality control” during the XXXV National Conference of Indian Association of Medical Microbiologists, Varanasi, November 23-26, 2011.
  92. Jayakumar R, Joshi YK,Singh S.Comparing three oral regimens for the treatment of Chronic Hepatitis B Infection: Tenofovir, Entecavir and combination of Lamivudine and Adefovir. Indian J Gastroenterol, 2011; 30 (suppl-1): 1-105.
  93. Singh S. Plenary Lecture on “Past, Present and future of Research in Medical Faculties” during the Annual conference of Association of Medical Biochemists of India (AMBICON2011) , Government Medical College, Tiruchirapalli, Tamilnadu from December 16-18, 2011
  94. Singh S. Guest lecture on “Point of care tests for kala-azar: during the Annual conference of Association of Medical Biochemists of India (AMBICON2011), Government Medical College, Tiruchirapalli,Tamilnadu from December 16-18, 2011.
  95. Singh S, Kumar S, Singh J, Balooni V, Singh S, Mani K. usefulness of Serology in the diagnosis of pulmonary Tuberculosis. Presented in the 112th Annual ASM meeting at San Francisco, USA, June 16-19, 2012.
  96. Singh S, Gupta A, Sharma P, Singh S. Development of strip based assay for the diagnosis of tuberculosis directly from patient serum. XXXVI National Conference of Indian Association of Medical Microbiologists (MICROCON-2012), New Delhi 25th Nov-27th Nov, 2012, TP-34: 285.
  97. Singh J, Sankar MM, Kadian S, Prajapati S, Singh S. Identification of predominant genotype of MTB among tuberculosis patients from different geographical locations of India. XXXIV Indian Association of Medical Microbiologists (MICROCON- 2012), New Delhi. 25th Nov- 27th Nov 2012, TO-11:111.
  98. Kumar P, Balooni V, Sharma B, Kapil V, Singh S. Usefulness of line probe assay for rapid diagnosis of MDR-TB. XXXVI National Conference of Indian Association of Medical Microbiologist (MICROCON-2012), New Delhi, 25th-27th Nov 2012.TO-10:110.
  99. Singh A, K Gopinath, P. Sharma, D. Bisht, N. Singh, Singh S. “Proteomics analysis of sequential isolates of M. tuberculosis from a patient of drug resistant pulmonary tuberculosis” FEMS2013, at Leizig, Germany, July 21st-25th2013.
  100. Singh J, Kadian S, Singh N, Singh S. “Genotyping of M. tuberculosis isolates by spoligotyping from South Delhi area, Delhi” FEMS2013, at Leizig, Germany, July 21st-25th 2013.
  101. Singh S. “Toxoplasmosis”. Proceedings of the 7th Annual Conference of Indian Academy of Tropical Parasitology from 6-8 September 2013 at SGPGI, Lucknow.
  102. Singh J, Singh N, Aggarwal U, Behera D, Singh S. “Genotypes and drug susceptibility pattern of Mycobacterium tuberculosisisolates in HIV Seropositive patients” 68th NATCON, NITRD, New Delhi, Feb 24th -26th 2014.
  103. Kumar P, Sharma S, Singh S. “Usefullness of non-commercial rapid DST methods for the detection of MDR-TB in resource limited settings”. 68TH NATCON, NITRD, New Delhi, from 23rd– 24th Feb 2014.
  104. Singh N, Singh J, Aggarwal U, Behera D, Singh S. “Differences in the population genetics of Mycobacterium tuberculosis between HIV seropositive and HIV seronegative patients.” 68th NATCON, NITRD, New Delhi, 24th -26th Feb 2014.
  105. Shankar P, Kumar M, Mishra J, Singh S. “Expression of cytokines in Balb/c mice immunized with Chimera DNA vaccine against Tuberculosis and Leishmania co-infection”. MBC on Leishmaniasis-2014, at Trieste, Italy, October 22nd-24th 2014.
  106. Rufai SB, Singh A, Kumar P, Singh J, Singh S.. “Performance of Xpert MTB/RIF for detection of Mycobacterium tuberculosis on pleural fluid samples from high burden setting”, IAMM, Delhi chapter, at VMCC & SJH, New Delhi on 25th April 2015.
  107. Kumar P, Rufai SB, Singh J, Singh S. “Loop Mediated Isothermal Amplification Assay for rapid detection of MTB, M. avium and NTM from clinical samples,” IAMM, Delhi chapter, at VMCC & SJH, New Delhi on 25th April 2015.
  108. Singh J, Sankar MM, Kumar P, Singh S. “A first appraisal of genetic diversity and drug susceptibility profile of Mycobacterium tuberculosis isolated from different geographical regions of India.” IAMM, Delhi Chapter, VMMC & SJH, New Delhi, 25th April 2015.
  109. Singh A, Gupta AK, Gopinath K, Sharma P, Singh S. “Preparation of Novel Recombinant Antigens for the Rapid Diagnosis of Drug Resistant Tuberculosis” accepted in ICAAC/ICC 2015 (ASM). San Diego, California, USA. September 17-21, 2015.
  110. Singh A, Gupta AK, Singh S. “Identification of novel biomarkers for rapid diagnosis of multidrug resistant tuberculosis”. Global Healthcare Summit 2016 (GHS 2016) research paper competition by AIIMS-AAPI, at AIIMS, New Delhi, India. December 29, 2015.
  111. Singh A, Gupta AK, Gopinath K, Sharma P, Singh S. “Preparation of Novel Recombinant Antigens for the Rapid Diagnosis of Drug Resistant Tuberculosis” accepted in ICAAC/ICC 2015 (ASM). San Diego, California, USA. September 17-21, 2015.
  112. Goel V, Balooni V, Kumar D, Singhal S, Ahmed S, Singh S. “Prevalence of HIV in a tertiary care hospital in Delhi: A five year hospital based study” AHPCON, AIIMS, New Delhi.; February 2016.
  113. Vats O, Goel V, Kumar D,Singh S. “Effects of cigarette consumption, tobacco chewing and alcohol intake on human seminal quality” AHPCON, AIIMS, New Delhi.; February 2016.
  114. Singh J, Sankar MM, Kumar P, Couvin D, Rastogi N, Singh S. and Indian TB Diagnostics Network. “Molecular characterization of Mycobacterium tuberculosis strains isolated in India.” ICID, Hyderabad, March 2nd – 5th, 2016.
  115. Singh S, Gupta AK, Srivastava S, Singh A, Shankar P. “Superinfection with an endosymbiotic bacterium Parvibaculumlavamentivorans leads to manifest Leishmania donovani as Post kala azar dermal leishmaniasis.” 26th ECCMID, at Amsterdam, Netherland, April 9th – 12th 2016.
  116. Singh A, Gupta AK, Gopinath K, Singh S. “Identification of novel point-of-care biomarkers: validation and evaluation for the rapid detection of TB and MDR-TB”. Microbe 2016 at Boston, USA. 16-21 June, 2016.
  117. Singh A, Gupta AK, Singh S. “Identification of novel biomarkers for rapid diagnosis of multidrug resistant tuberculosis”. Global Healthcare Summit, research paper competition by AIIMS-AAPI, at AIIMS, New Delhi, India. December 29, 2015.
  118. Sankar M, Singh J, Munawwar A, Kabra SK, Sood R, Praneeth M, Singh S. Genotypes of Mycobacterium tuberculosis isolated from blood of active tuberculosis patients. Int J Infect Dis 2016; 45 (Suppl 1): p-409. DOI:http://dx.doi.org/10.1016/j.ijid.2016.02.873.
  119. Singh S. Gupta AK, Srivastava S, Singh A, Shankar P. “Superinfection with an endosymbiotic bacterium Parvibaculumlavamentivorans leads to manifest Leishmania donovani as Post kala azar dermal leishmaniasis.” 26th ECCMID, at Amsterdam, Netherland, April 9th – 12th 2016.
  120. Singh A, Gupta AK, Gopinath K, Singh S. “Identification of novel point-of-care biomarkers: validation and evaluation for the rapid detection of TB and MDR-TB”. Microbe 2016 at Boston, USA. 16-21 June, 2016.
  121. Singh S. Haemoparasites: Toxoplasmosis. X National Conference of Indian Academcy of Parasitology. Pondicherry, India, November 4-6, 2016.
  122. Singh S. Advances in diagnosis of zoonotic parasitic diseases,40th National Conference of the Indian Association of Medical Microbiologists at Chandigarh during 23rd -27th November 2016.
  123. Singh S. MEET THE EXPERT: Control of vector borne parasitic. 40th National Conference of the Indian Association of Medical Microbiologists at Chandigarh during 23rd -27th November 2016.
  124. Singh S. Acute Hepatitis A and hepatitis E viral infections in Urban India: a hospital based study. 26th Conference of the Asian Pacific Association for the Study of the Liver (APASL). Shanghai, China, February 15-19, 2017.
  125. Singh S., Gupta AK, Gopinath K, Sharma D, Sharma P, Bisht D, Sharma P, Singh S. “Comparative proteomic analysis of sequential isolates of Mycobacterium tuberculosis sensitive and resistant Beijing type from a patient with pulmonary tuberculosis”. 2nd Asian African Congress of Mycobacteriology (AASM 2017), at Isfahan, Iran, 25-28 February 2017.
  126. Gupta A, Srivastava S, Singh A,Singh S. “Development of rapid immuno-diagnostic test for the early detection of tuberculosis.” 2nd AASM, at Iran, February 25th – 28th 2017.
  127. Rufai SB, Sankar MM, Singh J, Singh S. Predominance of Beijing lineage among pre-extensively drug-resistant and extensively drug-resistant strains of Mycobacterium tuberculosis: A tertiary care center experience.2nd AACM, at Iran, February 25th – 28th 2017.
  128. Gupta AK, Singh A, Sharma P, Singh S.. Discovering Novel Antigens for the Rapid Diagnosis and Prognosis of Tuberculosis. ASM Conference on Innovative Microbial Ecology for Mitigation of Antibiotic Resistance and Bacterial Diseases, Arlington,USA, March 22-25, 2017.
  129. Singh J, Rufai B S, Kumar P, Rawat S V, Ahmad H, Ajith J, Singh S. “Comparison of Abbott Real-Time MTB RIF/INH resistance assay with standard phenotypic and other molecular methods: a pilot study.” ECCMID, Vienna, Austria, April 22nd -25th 2017.
  130. Srivastava S, Mishra J, Gupta AK, Singh A, Mishra PS, Singh S. “Emergence of Miltefosine Resistant Cases of Visceral Leishmaniasis in India” 6th World Leish, Toledo, Spain, May 16th – 20th 2017.
  131. Gupta AK, Srivastava S, Singh A, Singh S. “Post kala-azar dermal leishmaniasis: is it a result of endosymbiotic infection of Leishmania with Parvibaculumlavamentivorans”. 6th World Leish, Toledo, Spain, May 16th – 20th 2017.
  132. Shankar P, Singh S. “Goat (Caprahircus) as a potential animal reservoir for kala-azar in India.” 6th World Leish, Toledo, Spain, May 16th – 20th 2017.
  133. Singh S. HIV/AIDS and leishmaniasis in India: Factors that contained the Epidemic of Co-infection. 6th World Leish, Toledo, Spain, May 16th – 20th 2017.